Axogen, Inc. AXGN
Set alert
At close
Pre-market · Nov 2, 6:04 AM ET
- YTD
- +50.84%
- 1 year
- +117.68%
- Open
- 49.70
- Prev close
- 49.63
- Mkt cap
- 2.95B
- Vol
- 1.84M
- Avg vol
- 1.39M
- EPS
- -0.63
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 48.08
- High
- 49.88
- Forward P/E
- 69.55
- Beta
- 1.17
- Short ratio
- 3.57
- Inst. own
- 95.98%
- Dividend
- 0.00
- Ex-div date
- Jan 26, 2010
- Earnings
- Feb 23, 2027
- 50-d avg
- 42.80
- 200-d avg
- 39.48
- 1y target
- 57.73
News
2 days ago seekingalpha.com
Axogen: Taking The Friction Out Of Nerve Repair
Axogen (AXGN) is evolving from a growth story to the default procedural platform in peripheral nerve repair, protected by a regulatory moat for the next decade. Q3 2026 saw 26% revenue growth, 45%…
-
3 days ago benzinga.com
Canaccord Genuity Maintains Buy on Axogen, Raises Price Target to $60
Canaccord Genuity analyst Caitlin Roberts maintains Axogen (NASDAQ:AXGN) with a Buy and raises the price target from $55 to $60.
-
3 days ago benzinga.com
Leerink Partners Maintains Outperform on Axogen, Raises Price Target to $56
Leerink Partners analyst Mike Kratky maintains Axogen (NASDAQ:AXGN) with a Outperform and raises the price target from $52 to $56.
-
3 days ago benzinga.com
Barclays Maintains Overweight on Axogen, Raises Price Target to $60
Barclays analyst Christopher Pasquale maintains Axogen (NASDAQ:AXGN) with a Overweight and raises the price target from $50 to $60.
3 days ago zacks.com
Is AxoGen (AXGN) Outperforming Other Medical Stocks This Year?
Here is how AxoGen (AXGN) and BioCryst Pharmaceuticals (BCRX) have performed compared to their sector so far this year.
-
3 days ago benzinga.com
Truist Securities Maintains Buy on Axogen, Raises Price Target to $60
Truist Securities analyst Ravi Misra maintains Axogen (NASDAQ:AXGN) with a Buy and raises the price target from $53 to $60.
-
3 days ago benzinga.com
Wells Fargo Maintains Overweight on Axogen, Raises Price Target to $56
Wells Fargo analyst Larry Biegelsen maintains Axogen (NASDAQ:AXGN) with a Overweight and raises the price target from $48 to $56.
3 days ago benzinga.com
Microsoft To Rally More Than 22%? Here Are 10 Top Analyst Forecasts For Thursday
Analysts raised targets for Microsoft, VF, Glaukos, Hilton, AxoGen and Brinker; Renasant’s target was cut and its rating downgraded.
-
4 days ago benzinga.com
HC Wainwright & Co. Maintains Buy on Axogen, Raises Price Target to $56
HC Wainwright & Co. analyst Yi Chen maintains Axogen (NASDAQ:AXGN) with a Buy and raises the price target from $53 to $56.
4 days ago marketbeat.com
AxoGen Q3 Earnings Call Highlights
AxoGen NASDAQ: AXGN reported third-quarter revenue growth of 26.2% as demand for its nerve-repair products increased across its breast, extremities, oral and maxillofacial, and head-and-neck markets.…
4 days ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Pulmonx (NASDAQ:LUNG) stock increased by 33.1% to $2.63 during Wednesday's regular session. The company's market cap stands at $85.0 million. As per the press release, Q3 earnings came out…
4 days ago benzinga.com
Crude Oil Surges Over 3%; Brinker Posts Upbeat Earnings
U.S. stocks were mixed; Dow and S&P 500 rose while Nasdaq slipped. Brinker beat estimates and raised guidance; oil jumped 3.4%.
4 days ago seekingalpha.com
Axogen, Inc. (AXGN) Q3 2026 Earnings Call Transcript
Axogen, Inc. (AXGN) Q3 2026 Earnings Call Transcript
4 days ago benzinga.com
Vertiv, Evercore, Brinker, GE HealthCare And Other Big Stocks Moving Higher On Wednesday
U.S. stocks mixed; Dow gained ~100 points. Vertiv jumped 13.3% on strong results and raised guidance; Ultralife soared 145.8% on buyout news.
4 days ago zacks.com
AxoGen (AXGN) Beats Q3 Earnings and Revenue Estimates
AxoGen (AXGN) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.12 per share a year ago.
4 days ago benzinga.com
Axogen Q3 2026 Earnings Call Transcript
Axogen (NASDAQ:AXGN) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
4 days ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Axogen (NASDAQ:AXGN) stock rose 17.7% to $44.1 during Wednesday's pre-market session. The market value of their outstanding shares is at $2.1 billion. As per the news, the Q3 earnings report…
-
4 days ago benzinga.com
Axogen Q3 Adj. EPS $0.21 Beats $0.14 Estimate, Sales $75.834M Beat $73.199M Estimate
Axogen (NASDAQ:AXGN) reported quarterly earnings of $0.21 per share which beat the analyst consensus estimate of $0.14 by 50 percent. This is a 75 percent increase over earnings of $0.12 per share…
5 days ago globenewswire.com
Axogen, Inc. Reports Third Quarter 2026 Financial Results
Raises Full Year Revenue Guidance to at Least 29% Growth or $290 million Raises Full Year Revenue Guidance to at Least 29% Growth or $290 million
-
1 week ago benzinga.com
Barclays Maintains Overweight on Axogen, Lowers Price Target to $50
Barclays analyst Christopher Pasquale maintains Axogen (NASDAQ:AXGN) with a Overweight and lowers the price target from $55 to $50.
2 weeks ago benzinga.com
This Robinhood Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Analysts initiated coverage on ASBH, QNRX, AXGN and HOOD with bullish ratings and targets; IDXX received a Sector Weight rating.
-
3 weeks ago benzinga.com
B of A Securities Initiates Coverage On Axogen with Buy Rating, Announces Price Target of $52
B of A Securities analyst Travis Steed initiates coverage on Axogen (NASDAQ:AXGN) with a Buy rating and announces Price Target of $52.